ispor europe

ISPOR Europe 2023


Remap Consulting joined over 4,100 other delegates in attending the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual International Meeting in Copenhagen, Denmark from 12th – 15th November 2023.

The theme for this year’s meeting was “HEOR at the Nexus of Policy and Science”. The theme was styled as a “thread” that was woven throughout many of the sessions to bring a fresh and holistic view of the importance of the HEOR community’s role in impacting the present and more over the future of innovation, value, and decision-making for health globally.

On this webpage you will find our daily summaries of the plenary sessions, post-conference report and the research that we presented at the conference.

Our team

Our conference team this year boast expertise spanning a wide range of areas, including health economics, RWE, market access, and HTA.

Our research posters

We’re delighted that our team showcased five distinct research topics at ISPOR Europe and had a great time engaging with you to discuss the research during the poster sessions and tours. For a more in-depth look, please click on the titles below to access the abstracts and posters.

PT21: Evaluation and Reimbursement of Digital Therapeutics in Germany, France, Belgium and England
HTA122: How Has NICE’s Severity Modifier Been Implemented?
PT26: How Aware Are Biotech and Pharmaceutical Companies of the Implementation of the New EU HTA?
HTA228: Can Just Three Picos be Feasible for Oncology Assessments with the Joint EU HTA Framework, Whilst Considering All 27 Member States Specificities?
EE700: Are Acute Therapies and Curative Drugs More Affordable Than Chronic Treatments in Rare Diseases? an Analysis of the Top 10 Most Expensive Drugs in the US Compared with Germany.


Just like in past years, Remap Consulting have crafted daily summaries of the essential conference topics, including the plenary sessions. Plus, for extra insights, subscribe to our newsletter below.

Day one summary
Day two summary
Day three summary

Read our in-depth complete conference report below

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.